When an Indian clinic sends you an IVF quote, the base price is rarely the final number. Underneath it sits a menu of optional “add-ons” — assisted hatching, time-lapse imaging, EmbryoGlue, PGT-A, endometrial tests — each promising a better chance of success, each adding to the bill. For international patients comparing clinics from abroad, this is where costs quietly balloon and where it’s hardest to know what you’re actually buying.
Here’s the uncomfortable truth most clinic websites won’t tell you: many popular IVF add-ons have little or no good evidence that they improve your chance of a baby. Not because clinics are dishonest, but because they sell these services and have little incentive to talk you out of them. This guide does the opposite. It applies the same evidence standard used by the UK’s fertility regulator to the add-ons Indian clinics actually offer — so you can tell the difference between an extra worth paying for and one that just raises the price.
The Quick Answer
- Some add-ons are genuinely useful — but only for specific patients. ICSI for male-factor infertility, PGT-M for a known inherited disease, or a freeze-all cycle to avoid OHSS are evidence-based when there’s a clinical reason for them.
- Many “routine” add-ons lack good evidence of improving live birth rates for the average patient — including assisted hatching, endometrial scratching, the ERA test, and IMSI.
- A few sit in between, with mixed or developing evidence — time-lapse imaging, EmbryoGlue, and PGT-A.
- The single most useful habit: ask the clinic to rate each add-on’s evidence and explain why you specifically need it. A good clinic welcomes that question.
What Is an IVF “Add-On”?
An IVF add-on is any optional procedure, technology, or medication offered on top of a standard IVF cycle, usually for an extra fee, on the promise of improving your chance of success. Standard IVF involves stimulating the ovaries, collecting eggs, fertilising them, growing embryos, and transferring one back. Everything layered on top of that core process — extra lab techniques, embryo tests, special culture fluids, immune treatments — is an add-on.
Add-ons aren’t inherently bad. Some are real advances for the right patient. The problem is that they’re frequently sold to everyone, regardless of whether the evidence supports using them in that person’s situation.
How to Judge an Add-On: the Traffic-Light Standard
The most respected framework for this comes from the UK’s Human Fertilisation and Embryology Authority (HFEA), the government regulator for fertility treatment. The HFEA reviews the scientific evidence for each add-on and gives it a rating. In October 2023 it expanded that system to five categories based on what the best studies show for a given patient group:
- Green — more than one good-quality study shows it improves the outcome.
- Amber / yellow — evidence is mixed or unclear; it can’t be called effective yet.
- Grey — there isn’t enough good evidence to rate it at all.
- Black — the evidence shows it makes no difference to the outcome.
- Red — there are potential safety concerns, or evidence of a negative effect.
Crucially, very few add-ons hold a green rating. The HFEA’s own guidance is blunt: where robust trials are lacking, add-ons “should be reconsidered to avoid false hope and unnecessary costs.” You can check the current rating of any add-on directly on the HFEA’s page at hfea.gov.uk/treatments/treatment-add-ons — it’s free, independent, and updated as new studies appear. Bookmark it before any clinic consultation.
The Add-Ons Indian Clinics Commonly Offer
Below is a plain-English summary of the add-ons you’re most likely to see on an Indian IVF quote, with approximate price ranges and what the evidence broadly says. Prices vary widely by clinic and city; treat these as indicative and always get a written, itemised quote.
| Add-on | What it is | Typical India price | What the evidence broadly says |
|---|---|---|---|
| ICSI | Injecting a single sperm directly into each egg | ₹20,000–45,000 (~$250–550) | Clearly useful for male-factor infertility; little benefit when sperm is normal |
| PGT-A | Screening embryos for chromosome number | ₹50,000–1,50,000+ (~$600–1,800) | May reduce miscarriage / time-to-pregnancy in selected older patients; does not raise live-birth rate per cycle for most — not recommended routinely |
| PGT-M | Testing embryos for a specific inherited disease | ₹1,00,000–2,00,000+ (~$1,200–2,400) | Evidence-based and appropriate when there’s a known genetic condition in the family |
| Time-lapse imaging | Camera incubator that films embryo development | ₹20,000–50,000 (~$250–600) | Mixed evidence; doesn’t clearly improve birth rates over standard culture |
| Assisted hatching | Thinning the embryo’s outer shell with a laser | ₹15,000–25,000 (~$180–300) | No good evidence it improves live birth for most patients |
| EmbryoGlue | Hyaluronate-rich transfer fluid | ₹5,000–15,000 (~$60–180) | Among the more favourably studied add-ons, but still debated; modest at best |
| Endometrial scratch | Deliberately scratching the womb lining before transfer | ₹5,000–15,000 (~$60–180) | Large trials found no benefit for most patients |
| ERA test | Biopsy to “time” the transfer window | ₹40,000–60,000 (~$480–720) | Trial evidence shows no improvement in live birth for the general population |
| Immune therapies (intralipids, steroids) | Treatments aimed at the immune system | Varies widely | Not recommended for routine use; potential risks — discuss carefully |
Add-Ons That Are Often Worth It — for the Right Patient
This isn’t an argument against all add-ons. Several are genuinely valuable when there’s a specific clinical reason:
- ICSI when there’s male-factor infertility (low count, poor motility) or a history of failed fertilisation. For couples with normal sperm, standard IVF fertilisation works just as well, so routine ICSI for everyone is harder to justify.
- PGT-M when you or your partner carry a known inherited condition. Testing embryos for that specific disease is well-established and can prevent passing it on.
- A freeze-all (elective frozen transfer) when you’re at risk of ovarian hyperstimulation syndrome (OHSS), or when you’re doing PGT and need time for results. As a blanket policy for everyone, the evidence is weaker.
The common thread: there’s a reason rooted in your diagnosis, not a one-size-fits-all upsell.
Add-Ons to Question for Routine Use
For the average patient without a specific indication, these are the ones to ask hard questions about before paying. Large, well-designed studies have generally failed to show that they raise live-birth rates when used routinely:
- Assisted hatching — long offered, but the weight of evidence doesn’t support a benefit for most.
- Endometrial scratching — early small studies looked promising; bigger trials since have not borne it out.
- The ERA test — a randomised trial found it didn’t improve live birth in the general IVF population.
- IMSI (high-magnification sperm selection) — no good evidence of benefit over standard ICSI for most.
- Immune treatments like intralipid infusions or steroids — not recommended for routine use and not without risk.
If a clinic recommends one of these, the right response isn’t an automatic “no” — it’s “what’s the evidence, and why do you think it applies to me?”
The Genuinely Uncertain Middle: PGT-A, Time-Lapse, EmbryoGlue
A few add-ons are neither clearly useful nor clearly useless — the evidence is still developing, and reasonable specialists disagree:
- PGT-A can reduce miscarriage and the number of failed transfers in selected older patients by avoiding chromosomally abnormal embryos — but for most patients it does not increase the chance of a baby per cycle started, and it adds significant cost. It’s a nuanced, individual decision, not a default.
- Time-lapse imaging is a nice technology that lets embryologists watch development without disturbing embryos, but studies haven’t reliably shown it produces more babies than standard culture.
- EmbryoGlue has somewhat more supportive data than most add-ons and is inexpensive, but the benefit, if real, is modest.
What This Means for Your Budget
Add-ons are where an attractive headline price becomes an expensive final bill. A base IVF cycle in India often runs roughly ₹1,50,000–2,50,000, but a stack of add-ons — PGT-A, time-lapse, assisted hatching, ERA — can push the total to ₹3,50,000–5,00,000 or more. In other words, unproven extras can add the price of a second cycle.
For an international patient, that’s money that might be better kept in reserve for a second attempt if the first doesn’t succeed — which is often a more reliable route to a baby than paying for add-ons with weak evidence. To see how the core numbers compare before any extras, use our IVF cost calculator and read our breakdown of what IVF really costs in India.
Five Questions to Ask Before Paying for Any Add-On
- “What’s the HFEA rating for this add-on?” A clinic confident in its recommendations won’t be thrown by the question.
- “Why do you recommend it for my specific situation?” Listen for a reason tied to your diagnosis, not a generic “it improves success rates.”
- “What does it cost, and is it in my written quote?” Get every add-on itemised in writing before you commit.
- “What happens to my chances if I decline it?” The honest answer for many add-ons is “very little.”
- “Is this included by default, and can I opt out?” Some clinics bundle add-ons into a package — make sure you’re not paying for extras you didn’t choose.
How Fertibridge Helps
This is exactly the kind of decision where an honest intermediary matters. When we match you with a verified clinic, we help you read the quote critically — separating the add-ons with a real clinical reason for your case from the ones that simply raise the price. We don’t earn more when you buy more add-ons, so our advice isn’t conflicted. Our role is to help you spend on what gives you the best genuine chance of a baby, and our consultation is free. You can also read how we think about clinic quality and standards in our guide to whether IVF in India is safe for foreign patients.
Frequently Asked Questions
Are IVF add-ons a scam?
No — but they’re frequently oversold. Some add-ons are genuinely valuable for specific patients (for example, ICSI for male-factor infertility or PGT-M for a known genetic condition). The issue is that many add-ons with little evidence of benefit are offered to everyone. The goal isn’t to refuse all extras; it’s to pay only for the ones with a real reason in your case.
Which IVF add-on has the best evidence?
Among the optional extras, EmbryoGlue (hyaluronate-enriched transfer medium) has historically had some of the more supportive data, and it’s inexpensive. Procedures used for a clear clinical indication — ICSI for male factor, PGT-M for inherited disease — are well-established. For most “routine” add-ons offered to everyone, the evidence is weak. Always check the current rating on the HFEA website.
Does PGT-A improve my chance of a baby?
For most patients, PGT-A does not increase the live-birth rate per cycle started. It can reduce miscarriage and the number of failed transfers in selected older patients by screening out chromosomally abnormal embryos, but it adds substantial cost and isn’t recommended as a routine test for everyone. It’s an individual decision to discuss carefully with your doctor.
Why do Indian clinics offer so many add-ons?
The same reasons clinics worldwide do: some genuinely believe in them, patients ask for “everything that might help,” and add-ons are a source of revenue. India’s leading clinics use the same technologies as Western ones — which means the same evidence questions apply. Being on a medical-tourism budget makes it even more worthwhile to spend only on extras that are justified for you.
Can I just decline all add-ons?
You can decline any add-on, and for many patients a standard IVF cycle is entirely appropriate. But don’t decline blindly either — a few add-ons matter for specific situations. The best approach is an informed conversation with your doctor about which, if any, are indicated for your diagnosis.
This article is general information to help you ask better questions — it is not medical advice, and the right treatment plan depends on your individual circumstances. Always discuss add-ons with a qualified fertility specialist, and check current evidence ratings on the HFEA website. See our medical disclaimer. Last reviewed June 2026.